Restart Life Sciences Corp.
HEAL
Clasificación en acciones
#35838
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Precio por acción
$0.05137558
Última sincronización: 2026-10-16
Capitalización bursátil
$3.21M
Cambio (1 día)
0.00%
Cambio (1 año)
78.84%
País
CA
Comercio Restart Life Sciences Corp. (HEAL)
Categoría
Healthcare
Ratio P/B de Restart Life Sciences Corp. (HEAL)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Restart Life Sciences Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Restart Life Sciences Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | - |
NL
|
